Author:
Fiegenbaum M,Silveira F R,Van der Sand C R,Van der Sand L C,Ferreira M E W,Pires R C,Hutz M H
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference29 articles.
1. Pignone M, Phillips C, Multow C . Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ 2001; 321: 1–5.
2. Vaughan CJ, Gotto AM, Basson CT . The evolving role of statins in management of atherosclerosis. J Am Coll Cardiol 2000; 35: 1–10.
3. Gotto AM . Emerging perspectives on lipid management: international approaches and global challenges. Am J Cardiol 2001; 88: 876–881.
4. Maitland-van der Zee AH, Klungel OH, Stricker BHC, Verschuren WMM, Kastelein JJP, Leufkens HGM et al. Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors. Atherosclerosis 2002; 163: 213–222.
5. Hoffman MM, Winkelmann BR, Wieland H, Marz W . The significance of genetic polymorphisms in modulating the response to lipid-lowering drugs. Pharmacogenomics 2001; 2: 1–11.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献